RedHill Biopharma Ltd. (RDHL)

USD 2.07

(-3.72%)

Long Term Debt Summary of RedHill Biopharma Ltd.

  • RedHill Biopharma Ltd.'s latest annual long term debt in 2023 was 455 Thousand USD , down -92.94% from previous year.
  • RedHill Biopharma Ltd.'s latest quarterly long term debt in 2023 FY was 455 Thousand USD , down -92.94% from previous quarter.
  • RedHill Biopharma Ltd. reported annual long term debt of 6.44 Million USD in 2022, down -92.53% from previous year.
  • RedHill Biopharma Ltd. reported annual long term debt of 86.19 Million USD in 2021, up 1.17% from previous year.
  • RedHill Biopharma Ltd. reported quarterly long term debt of 994 Thousand USD for 2023 Q2, down -83.47% from previous quarter.
  • RedHill Biopharma Ltd. reported quarterly long term debt of 6.01 Million USD for 2023 Q1, down -6.64% from previous quarter.

Annual Long Term Debt Chart of RedHill Biopharma Ltd. (2023 - 2011)

Historical Annual Long Term Debt of RedHill Biopharma Ltd. (2023 - 2011)

Year Long Term Debt Long Term Debt Growth
2023 455 Thousand USD -92.94%
2022 6.44 Million USD -92.53%
2021 86.19 Million USD 1.17%
2020 85.19 Million USD 2757.87%
2019 2.98 Million USD 0.0%
2018 - USD 0.0%
2017 - USD 0.0%
2016 - USD 0.0%
2015 - USD 0.0%
2014 - USD 0.0%
2013 - USD 0.0%
2012 - USD 0.0%
2011 - USD 0.0%

Peer Long Term Debt Comparison of RedHill Biopharma Ltd.

Name Long Term Debt Long Term Debt Difference
Esperion Therapeutics, Inc. 501.54 Million USD 99.909%
Theratechnologies Inc. 51.26 Million USD 99.112%
Safety Shot Inc 304.9 Thousand USD -49.226%
Cosmos Health Inc. 3.03 Million USD 85.01%
Cronos Group Inc. 1.55 Million USD 70.815%
Ironwood Pharmaceuticals, Inc. 498.3 Million USD 99.909%
Kala Pharmaceuticals, Inc. 34.19 Million USD 98.669%
Organogenesis Holdings Inc. 60.74 Million USD 99.251%
Universe Pharmaceuticals INC - USD -Infinity%
ProPhase Labs, Inc. 10.25 Million USD 95.564%
Sonoma Pharmaceuticals, Inc. 87 Thousand USD -422.989%
Dynavax Technologies Corporation 252.41 Million USD 99.82%
Radius Health, Inc. 339.66 Million USD 99.866%
China SXT Pharmaceuticals, Inc. 117.12 Thousand USD -288.461%
Alvotech 1.02 Billion USD 99.956%
Sunshine Biopharma, Inc. 539.03 Thousand USD 15.59%
Alpha Teknova, Inc. 13.25 Million USD 96.566%
Intra-Cellular Therapies, Inc. 13.32 Million USD 96.586%
SCYNEXIS, Inc. 12.15 Million USD 96.258%
Harrow Health, Inc. 183.17 Million USD 99.752%
Biofrontera Inc. 804 Thousand USD 43.408%
DURECT Corporation 2.7 Million USD 83.161%
Supernus Pharmaceuticals, Inc. 33.19 Million USD 98.629%
ANI Pharmaceuticals, Inc. 309.66 Million USD 99.853%
OptiNose, Inc. 611 Thousand USD 25.532%
Aquestive Therapeutics, Inc. 91.07 Million USD 99.5%
Cumberland Pharmaceuticals Inc. 12.78 Million USD 96.441%
SIGA Technologies, Inc. 335.99 Thousand USD -35.42%
Lifecore Biomedical, Inc. 120.51 Million USD 99.622%
Shineco, Inc. 10.01 Million USD 95.458%
Phibro Animal Health Corporation 458.28 Million USD 99.901%
Procaps Group S.A. 28.41 Million USD 98.398%
TherapeuticsMD, Inc. 6.53 Million USD 93.034%
Regencell Bioscience Holdings Limited - USD -Infinity%
Viatris Inc. 16.18 Billion USD 99.997%
Sunshine Biopharma, Inc. 539.03 Thousand USD 15.59%
Rockwell Medical, Inc. 8.29 Million USD 94.513%
Incannex Healthcare Limited 210 Thousand USD -116.667%
Aytu BioPharma, Inc. 10.87 Million USD 95.817%
Tilray Brands, Inc. 287.93 Million USD 99.842%
Collegium Pharmaceutical, Inc. 489.96 Million USD 99.907%
PetIQ, Inc. 437.82 Million USD 99.896%
Silver Spike Investment Corp. - USD -Infinity%
Neurocrine Biosciences, Inc. 258.3 Million USD 99.824%
Journey Medical Corporation 14.62 Million USD 96.888%
Alimera Sciences, Inc. 64.48 Million USD 99.294%
Petros Pharmaceuticals, Inc. 6.85 Million USD 93.365%
Assertio Holdings, Inc. 38.51 Million USD 98.819%
Shuttle Pharmaceuticals Holdings, Inc. 135.08 Thousand USD -236.815%
Embecta Corp. 1.62 Billion USD 99.972%
Cyclo Therapeutics, Inc. 22.48 Thousand USD -1923.661%
Procaps Group, S.A. 28.41 Million USD 98.398%
PainReform Ltd. 30 Thousand USD -1416.667%
Avadel Pharmaceuticals plc 32.75 Million USD 98.611%
Hempacco Co., Inc. 5.93 Million USD 92.328%
Talphera, Inc. - USD -Infinity%
Pacira BioSciences, Inc. 513.79 Million USD 99.911%
Alvotech 1.02 Billion USD 99.956%
Lantheus Holdings, Inc. 616.12 Million USD 99.926%
Kamada Ltd. 7.43 Million USD 93.883%
Indivior PLC 235.66 Million USD 99.807%
Currenc Group, Inc. 2.5 Million USD 81.851%
Evoke Pharma, Inc. 5 Million USD 90.9%
Flora Growth Corp. 942 Thousand USD 51.699%
Cyclo Therapeutics, Inc. 22.48 Thousand USD -1923.661%
Evolus, Inc. 120.35 Million USD 99.622%
HUTCHMED (China) Limited 48.18 Million USD 99.056%
Amphastar Pharmaceuticals, Inc. 589.19 Million USD 99.923%
Akanda Corp. 2.49 Million USD 81.779%